Bottom line
HCPSX vs PRHSX: the short answer
HCPSX (Health Care Ultrasector Profund) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both mutual funds.
But PRHSX is far broader, holding 279 positions to 69 for HCPSX, so beyond the top names it adds exposure HCPSX doesn't have.
PRHSX is cheaper at 0.83% vs 2.76% — a difference of $193 a year per $10,000 invested.
Over five years, HCPSX returned +5.3% a year vs +4.2% for PRHSX (reporting dates differ).
Updated Nov 19, 2026
HCPSX vs PRHSX side by side
| HCPSX | PRHSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | ProShares | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 2.76% | 0.83% |
| Annual cost per $10k | $276 | $83 |
| 10-yr cost on $10k (prospectus) | $3,090 | $1,025 |
| Max front load | — | — |
| 12b-1 fee | 1% | — |
| 1-yr return | −2.4% | +17.7% |
| 5-yr return (annualized) | +5.3% | +4.2% |
| 10-yr return (annualized) | +8.1% | +9.1% |
| Best quarter | — | +23.5% |
| Worst quarter | — | −15.8% |
| Net assets (fund) | $12.1M | $11.9B |
| Number of holdings | 69 | 279 |
| Portfolio turnover | 99% | 62% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
16 of HCPSX's top 25 holdings also appear in PRHSX's top 25.
| Holding | HCPSX | PRHSX |
|---|---|---|
| Eli Lilly & Company | 11.83% | 14.28% |
| Johnson & Johnson | 8.03% | 6.63% |
| Abbvie Inc | 5.77% | 5.10% |
| Unitedhealth Group Inc | 4.90% | 5.99% |
| Merck & Company Inc | 4.19% | 4.01% |
| Thermo Fisher Scientific Inc | 2.78% | 2.52% |
| Amgen Inc | 2.71% | 1.82% |
| Abbott Laboratories | 2.40% | 1.89% |
| Gilead Sciences Inc | 2.10% | 2.82% |
| Bristol-myers Squibb Company | 1.74% | 2.11% |
| Cvs Health Corp | 1.73% | 0.94% |
| Intuitive Surgical Inc | 1.63% | 1.87% |
| Danaher Corp | 1.60% | 1.43% |
| Vertex Pharmaceuticals Inc | 1.57% | 2.28% |
| Stryker Corp | 1.46% | 1.78% |
Source: SEC Form N-PORT
HCPSX top 10
- Eli Lilly & Company — 11.83%
- Johnson & Johnson — 8.03%
- N/a — 6.45%
- Abbvie Inc — 5.77%
- N/a — 4.97%
- Unitedhealth Group Inc — 4.90%
- Merck & Company Inc — 4.19%
- N/a — 3.96%
- N/a — 3.96%
- N/a — 3.11%
PRHSX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
FAQ
What is the difference between HCPSX and PRHSX?
Which is cheaper, HCPSX or PRHSX?
Should I own both HCPSX and PRHSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.